NCAM1 and gastric cancer: However, although significant differences were demonstrated in flow cytometric analyses for CD3-CD56+dimTLR-9+ and CD3-CD56+brightTLR-9+ between younger and older GC patients, these changes could not be confirmed in genetic analyses.